Artiva Biotherapeutics Inc. (ARTV) Stock Price, Quote & News

Company Profile

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vascul...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 267 4467

Website: www.artivabio.com

Address:

5505 Morehouse Drive, Suite 100, San Diego, United States

csabuus May. 4 at 4:37 PM

$ARTV

0 · Reply

AnomalyDetective May. 4 at 1:52 PM

$PACK (Week 19 MDA) breakout chart the first of 4 new weekly picks up over 10% through Monday morning with average gains for the portfolio up +8.1% from Friday for members. 💥 Extending the count to 366 weeks with at least one pick again over 10% in less than a week. 💥 MDA breakout portfolio up +84.1% YTD in average cumulative returns vs #SPX S&P 500 up +5.91% YTD. Consider prior picks on the MDA charts like $KOPN $INDI $ABSI $ARTV Up to 12,600 daily breakout picks per year available at http://vmbreakouts.com and free breakout blog at http://top.vmbreakouts.com @vmbreakouts

0 · Reply

Papermoon347 May. 1 at 4:23 PM

$ARTV

0 · Reply

topstockalerts Apr. 30 at 8:01 PM

$ARTV kinda feels like it wants to move when people least expect it

0 · Reply

FuegoFiesta Apr. 30 at 6:33 PM

Have you missed the AKAN Squeeze ?! Looks like the chinese small cap operators are sending another one now.. RYOJ is a next ticker with only about 300 watchers on Stocktwits and recent great news. RYOJ is completely under the radar. With its super tiny float, It squeezed 500%+ recently ! Starting to breakout and, could we HALT UP in to close?! Zeta on $BTAI $SOGP $ARTV $OBAI OPU

0 · Reply

BillionerOfKing Apr. 30 at 6:28 PM

$ARTV Current Stock Price: $10.28

0 · Reply

FuegoFiesta Apr. 30 at 5:32 PM

Have you missed the AKAN & RDAC Squeezes?! Are you tired of being late and chasing?? RYOJ is a new IPO ticker with only about 200 watchers on Stocktwits and recent great news. RYOJ is completely under the radar. With its super tiny float, It squeezed from 2$ to +10$ before. Starting to SQUEEZE NOW! I took a heavy position and looking for a big profit short term. You do you. We in to $NKTR $VWAV $ARTV and $BTW.X now!

0 · Reply

Papermoon347 Apr. 30 at 1:41 PM

$ARTV Might be last chance to buy before $18-$2

0 · Reply

Papermoon347 Apr. 28 at 2:46 PM

$ARTV Always a take down before a take up !

3 · Reply

swinda42 Apr. 28 at 2:27 PM

$ARTV who has positive info on this

0 · Reply

Artiva Biotherapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 26 days ago

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Mar 10, 2026, 4:05 PM EDT - 7 weeks ago

Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Mar 4, 2026, 1:10 PM EST - 2 months ago

Artiva Biotherapeutics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 25, 2026, 8:00 AM EST - 2 months ago

Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 8:00 AM EST - 2 months ago

Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant

Feb 19, 2026, 8:00 AM EST - 2 months ago

Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors

Jan 21, 2026, 8:00 AM EST - 3 months ago

Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL

Nov 18, 2025, 7:00 AM EST - 5 months ago

Artiva Biotherapeutics Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 11:30 AM EST - 6 months ago

Artiva Biotherapeutics Transcript: TD Cowen Immunology and Inflammation Summit

Nov 12, 2025, 8:00 AM EST - 6 months ago

Artiva Biotherapeutics Transcript: Study Update

Nov 12, 2025, 7:20 AM EST - 6 months ago

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease

Nov 12, 2025, 7:00 AM EST - 6 months ago

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 3, 2025, 4:05 PM EST - 6 months ago

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Oct 30, 2025, 4:17 PM EDT - 6 months ago

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

$Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update$

Oct 16, 2025, 4:05 PM EDT - 7 months ago

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

Sep 3, 2025, 9:45 AM EDT - 8 months ago

Artiva Biotherapeutics Transcript: Cantor Global Healthcare Conference 2025

Aug 25, 2025, 4:05 PM EDT - 8 months ago

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Aug 6, 2025, 4:05 PM EDT - 9 months ago

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

Jun 4, 2025, 9:20 AM EDT - 11 months ago

Artiva Biotherapeutics Transcript: Jefferies Global Healthcare Conference 2025

May 28, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

May 13, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

May 8, 2025, 8:00 AM EDT - 1 year ago

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Apr 28, 2025, 4:35 PM EDT - 1 year ago

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Apr 8, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Apr 7, 2025, 11:00 AM EDT - 1 year ago

Artiva Biotherapeutics Transcript: 24th Annual Needham Virtual Healthcare Conference

Mar 31, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 24, 2025, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Mar 5, 2025, 2:30 PM EST - 1 year ago

Artiva Biotherapeutics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 20, 2025, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Jan 29, 2025, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Nov 20, 2024, 10:30 AM EST - 1 year ago

Artiva Biotherapeutics Transcript: Jefferies London Healthcare Conference 2024

Nov 12, 2024, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 11, 2024, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Oct 22, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Sep 10, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 13, 2024, 2:14 PM EDT - 1 year ago

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Jul 18, 2024, 7:08 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

csabuus May. 4 at 4:37 PM

$ARTV

0 · Reply

AnomalyDetective May. 4 at 1:52 PM

0 · Reply

Papermoon347 May. 1 at 4:23 PM

$ARTV

0 · Reply

topstockalerts Apr. 30 at 8:01 PM

$ARTV kinda feels like it wants to move when people least expect it

0 · Reply

FuegoFiesta Apr. 30 at 6:33 PM

0 · Reply

BillionerOfKing Apr. 30 at 6:28 PM

$ARTV Current Stock Price: $10.28

0 · Reply

FuegoFiesta Apr. 30 at 5:32 PM

0 · Reply

Papermoon347 Apr. 30 at 1:41 PM

$ARTV Might be last chance to buy before $18-$2

0 · Reply

Papermoon347 Apr. 28 at 2:46 PM

$ARTV Always a take down before a take up !

3 · Reply

swinda42 Apr. 28 at 2:27 PM

$ARTV who has positive info on this

0 · Reply

theBigDollarski Apr. 22 at 7:37 PM

$NKTX this should rationally be trading around 6 compared to $ARTV and $KYTX.

0 · Reply

swinda42 Apr. 22 at 1:53 PM

$ARTV whats happening why is everyone selling

0 · Reply

kil0gho5t Apr. 21 at 2:46 PM

$OCGN $ARTV $LAES $AKBA This is what a bad alert looks like Alerted december 21st 22nd is first day open after alert. Price 4.72 second alert sent 9th january by 9th feb its down $1.10 or 24% then the move starts. Calling a 180% gain without disclosing most would of been stopped out much earlier is the definition of promotion. $500 for this crap and to be called a vip.

0 · Reply

kil0gho5t Apr. 21 at 2:43 PM

$OCGN $ARTV $LAES $AKBA lets just highlight what a good alert looks like. Marked on chart for easy viewing and no manipulation. Alert 11th aug, continued uptrend position never once red 152% gain. No subscriptions no charges just free ideas.

1 · Reply

Geraldgenofranco1953 Apr. 21 at 2:12 PM

$ARTV Amazing call Jack I made 150% here. Thank you

0 · Reply

hbkstockislife Apr. 21 at 2:08 PM

$ARTV so xbi up 1% thi does 10-20% and xbi down 1% this one does -1% wow

0 · Reply

jacksparo Apr. 20 at 8:26 PM

$ARTV If anyone got this from my December 2025 email will be in a big big gain by now! Everything documented! And it got comfortably to the entry range and what a trade! 250% almost!

1 · Reply

KUMO2026 Apr. 20 at 6:24 PM

$ARTV little extended another day hold

0 · Reply

ap20 Apr. 17 at 11:23 AM

$ARTV Added.

0 · Reply

MMCGON333 Apr. 16 at 10:48 PM

$ARTV I bought at $12.15. Probably not the best decision I have ever made but torn about selling it now or waiting until tomorrow.

0 · Reply

KUMO2026 Apr. 16 at 7:53 PM

$ARTV very nice move on this break out

0 · Reply

ap20 Apr. 16 at 7:45 PM

$ARTV I looked away for a bit and missed the 11’s. Sort of a great rip-off.

0 · Reply

Market Cap	N/A
Revenue (ttm)	33.49M
Net Income (ttm)	-27.70M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	342,500
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A